These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12607346)

  • 1. [The utility of the Pneumonia PORT prediction rule for evaluating the severity of community-acquired pneumonia in Japan. The relationship between disease severity and drug-resistant Streptococcus pneumoniae].
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura M; Shimizu J
    Kansenshogaku Zasshi; 2002 Dec; 76(12):1003-9. PubMed ID: 12607346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
    Mufson MA; Chan G; Stanek RJ
    Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital.
    Watanabe H; Sato S; Kawakami K; Watanabe K; Oishi K; Rikitomi N; Ii T; Ikeda H; Sato A; Nagatake T
    Respirology; 2000 Mar; 5(1):59-64. PubMed ID: 10728733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
    Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae].
    Maekawa M; Fukuda Y; Sugiura Y; Kamiyama T; Futakuchi N; Takahata M; Mitsuyama J
    Jpn J Antibiot; 2003 Feb; 56(1):27-35. PubMed ID: 12723396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    Fukuoka T; Inoue H; Abe T; Ohya S
    Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic resistance of clinical isolates Streptococcus pneumoniae].
    Komori T; Takabayashi T; Kuse T; Nishino K; Suzuki K; Fujita N; Yoshimura M
    Rinsho Byori; 1996 May; 44(5):465-70. PubMed ID: 8676567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
    Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
    Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
    Noreddin AM; El-Khatib WF; Aolie J; Salem AH; Zhanel GG
    Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
    Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F
    N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
    Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
    J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.